J Korean Med Assoc.  2003 Sep;46(9):772-781. 10.5124/jkma.2003.46.9.772.

Epidemiology of Depressive Disorder

• Cho MJ
• Lee JY

• KMID: 2183117
• DOI: http://doi.org/10.5124/jkma.2003.46.9.772

Abstract

In Korea, the prevalence of major depression is 4 per 100 and the world prevalence is 10 per 100. Risk factors are women, younger cohort, separated and divorced, persons with family history, early parental death and disruptive childhood environment, negative stressful events and chronic stress, absence of confidant in women, and urban areas. The mean age of onset ranges from late twenties to early thirties, but the age of onset becomes earlier and the prevalence of major depression is increasing. The recurrence rate is 85% and patients experience four episodes of depression on average and major depression is ranked as the fourth disabling disease. It was proven that major depression is one of most chronic and disabling diseases. The prognosis is poorer with comorbid dysthymia. Anxiety disorder, substance dependence, and hypothyroidism are frequent comorbid conditions with depression. And coronary arterial disease and stroke are also frequent comorbidities and their mortality rates increase with depression. The diathesis-stress model of depression is supported by the genetic study of depression. In conclusion, the rate of depression is rising and depression is one of the most chronic and disabling diseases. Therefore, I hope the disease be prevented through future studies.

Keyword

Major depression; Dysthymia; Epidemiology; Prevalence; Prevention

MeSH Terms

Age of Onset
Anxiety Disorders
Cohort Studies
Comorbidity
Depression
Depressive Disorder*
Divorce
Epidemiology*
Female
Hope
Humans
Hypothyroidism
Korea
Life Change Events
Mortality
Parental Death
Prevalence
Prognosis
Recurrence
Risk Factors
Stroke
Substance-Related Disorders

Figure

• 

  Figure 1

• 

  Figure 2

• 

  Figure 3

Reference

1. World Health Organization. Burden of mental and behavioral disorders, in World Health Report. 2001. Geneva: World Health Organization;19–46.

2. Guze SB, Robins E. Suicide and primary affective disorders. Br J Psychiatry. 1970. 117(539):437–438.

3. McQuaid JR, Stein MB, Laffaye C, McCahill ME. Depression in a primary care clinic:the prevalence and impact of an unrecognized disorder. J Affect Disord. 1999. 55(1):1–10.

4. World Health Organization. Mental disorders: glossary and guide to their classification in accordance with the 9th revision of the International Classification of Diseases. 1978. Geneva: WHO.

5. American Psychiatric Association. Diagnostic and Statistical Manual of mental disorders. 1980. 3rd ed. Washington DC: American Psychiatric Association Press.

6. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Kendler KS, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994. 51(1):8–19.

7. Weissman MM, Leaf PJ, Tischler GL, Blazer DG, Karno M, Florio LP, et al. Affective disorders in five United States communities. Psychol Med. 1988. 18(1):141–153.

8. Lee CK, Kwak YS, Yamamoto J, Rhee H, Kim YS, Lee YH, et al. Psychiatric epidemiology in Korea. Part II:Urban and rural differences. J Nerv Ment Dis. 1990. 178(4):247–252.

9. Cho MJ. Development of the Korean version of diagnostic instruments and epidemiological studies for major psychiatric disorders. 2001. Seoul: Ministry of Health & Welfare.

10. American Psychiatric Association. Diagnostic and Statistical Manual of mental disorders. 1994. 4th ed. Washington DC: American Psychiatric Association Press.

11. Bland RC, Orn H, Newman SC. Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand Suppl. 1988. 338:24–32.

12. Henderson AS, Jorm AF, MacKinnon A, Christensen H, Scott LR, Doyle C, et al. The prevalence of depressive disorders and the distribution of depressive symptoms in later life : a survey using Draft ICD-10 and DSM-III-R. Psychol Med. 1993. 23(3):719–729.

13. Hodiamont P, Peer N, Syben N. Epidemiological aspects of psychiatric disorder in a Dutch health area. Psychol Med. 1987. 17(2):495–505.

14. Hwu HG, Yeh EK, Chang LY. Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule. Acta Psychiatr Scand. 1989. 79(2):136–147.

15. Joyce PR, Oakley-Browne MA, Wells JE, Bushnell JA, Hornblow AR. Birth cohort trends in major depression : increasing rates and earlier onset in New Zealand. J Affect Disord. 1990. 18(2):83–89.

16. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Wang PS, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003. 289(23):3095–3105.

17. Vazquez-Barquero JL, Diez-Manrique JF, Pena C, Quintanal RG, Labrador Lopez M. Two stage design in a community survey. Br J Psychiatry. 1986. 149:88–97.

18. Cassem EH. Depressive disorders in the medically ill. An overview. Psychosomatics. 1995. 36(2):S2–S10.

19. Eaton WW, Kramer M, Anthony JC, Dryman A, Shapiro S, Locke BZ. The incidence of specific DIS/DSM-III mental disorders : data from the NIMH Epidemiologic Catchment Area Program. Acta Psychiatr Scand. 1989. 79(2):163–178.

20. Kelsoe J. Sadock B, Sadock V, editors. Mood disorders: Epidemiology, in Comprehensive textbook of psychiatry. 2000. Philadelphia: Lippincott Williams & Wilkins;1298–1307.

21. Kendler KS, Kessler RC, Walters EE, MacLean C, Neale MC, Eaves LJ, et al. Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry. 1995. 152(6):833–842.

22. Klerman GL, Weissman MM. Increasing rates of depression. JAMA. 1989. 261(15):2229–2235.

23. Cross-National Collaborative Group. The changing rate of major depression. Cross-national comparisons. JAMA. 1992. 268(21):3098–3105.

24. Kessler RC, Zhao S, Blazer DG, Swartz M. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord. 1997. 45(1-2):19–30.

25. Weissman MM, Myers JK. Affective disorders in a US urban community:the use of research diagnostic criteria in an epidemiological survey. Arch Gen Psychiatry. 1978. 35(11):1304–1311.

26. Bothwell S, Weissman MM. Social impairments four years after an acute depressive episode. Am J Orthopsychiatry. 1977. 47(2):231–237.

27. Hwu HG, Chang IH, Yeh EK, Chang CJ, Yeh LL. Major depressive disorder in Taiwan defined by the Chinese diagnostic Interview Schedule. J Nerv Ment Dis. 1996. 184(8):497–502.

28. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Yeh EK, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996. 276(4):293–299.

29. Kleinman A. Neurasthenia and depression:a study of somatization and culture in China. Cult Med Psychiatry. 1982. 6(2):117–190.

30. Keller MB, Lavori PW, Mueller TI, Endicott J, Coryell W, Shea T, et al. Time to recovery chronicity and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 1992. 49(10):809–816.

31. Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Maser JD, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry. 1999. 156(7):1000–1006.

32. Mueller TI, Keller MB, Leon AC, Solomon DA, Shea MT, Endicott J, et al. Recovery after 5 years of unremitting major depressive disorder. Arch Gen Psychiatry. 1996. 53(9):794–799.

33. Keller MB, Klein DN, Hirschfeld RM, Kocsis JH, McCullough JP, Mavin DB, et al. Results of the DSM-IV mood disorders field trial. Am J Psychiatry. 1995. 152(6):843–849.

34. Mueller TI, Leon AC. Recovery, chronicity, and levels of psychopathology in major depression. Psychiatr Clin North Am. 1996. 19(1):85–102.

35. Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am. 1996. 19(2):179–200.

36. Petronis KR, Samuels JF, Moscicki EK, Anthony JC. An epidemiologic investigation of potential risk factors for suicide attempts. Soc Psychiatry Psychiatr Epidemiol. 1990. 25(4):193–199.

37. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population : results from the US National Comorbidity Survey. Br J Psychiatry Suppl. 1996. (30):17–30.

38. Moos RH, Mertens JR. Patterns of diagnoses, comorbidities, and treatment in late-middle-aged and older affective disorder patients : comparison of mental health and medical sectors. J Am Geriatr Soc. 1996. 44(6):682–688.

39. Wittchen HU, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1994. 51(5):355–364.

40. Horwath E, Johnson J, Weissman MM, Hornig CD. The validity of major depression with atypical features based on a community study. J Affect Disord. 1992. 26(2):117–125.

41. Martin CS, Arria AM, Mezzich AC, Bukstein OG. Patterns of polydrug use in adolescent alcohol abusers. Am J Drug Alcohol Abuse. 1993. 19(4):511–521.

42. Conte HR, Karasu TB. A review of treatment studies of minor depression : 1980-1991. Am J Psychother. 1992. 46(1):58–74.

43. Roy-Byrne PP, Stang P, Wittchen HU, Ustun B, Walters EE, Kessler RC. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms impairment, course and help-seeking. Br J Psychiatry. 2000. 176:229–235.

44. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry. 1995. 52(2):89–99.

45. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 1996. 93(11):1976–1980.

46. Franco-Bronson K. The management of treatment-resistant depression in the medically ill. Psychiatr Clin North Am. 1996. 19(2):329–350.

47. Morris PL, Robinson RG, Samuels J. Depression, introversion and mortality following stroke. Aust N Z J Psychiatry. 1993. 27(3):443–449.

48. Scott TF, Allen D, Price TR, McConnell H, Lang D. Characterization of major depression symptoms in multiple sclerosis patients. J Neuropsychiatry Clin Neurosci. 1996. 8(3):318–323.

49. Kishi Y, Robinson RG, Forrester AW. Prospective longitudinal study of depression following spinal cord injury. J Neuropsychiatry Clin Neurosci. 1994. 6(3):237–244.

50. Blumer D, Montouris G, Hermann B. Psychiatric morbidity in seizure patients on a neurodiagnostic monitoring unit. J Neuropsychiatry Clin Neurosci. 1995. 7(4):445–456.

51. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression : review and meta-analysis. Am J Psychiatry. 2000. 157(10):1552–1562.

52. von Knorring AL, Bohman M, Sigvardsson S. Early life experiences and psychiatric disorders:an adoptee study. Acta Psychiatr Scand. 1982. 65(4):283–291.

53. Cadoret RJ, O'Gorman TW, Heywood E, Troughton E. Genetic and environmental factors in major depression. J Affect Disord. 1985. 9(2):155–164.

54. Wender PH, Kety SS, Rosenthal D, Schulsinger F, Ortmann J, Lunde I. Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry. 1986. 43(10):923–929.

55. Stancer HC, Weitkamp LR, Persad E, Flood C, Jorna T, Yagnow RL, et al. Confirmation of the relationship of HLA (chromosome 6) genes to depression and manic depression. II. The Ontario follow-up and analysis of 117 kindreds. Ann Hum Genet. 1988. 52(Pt 4):279–298.

56. Wilson AF, Tanna VL, Winokur G, Elston RC, Hill EM. Linkage analysis of depression spectrum disease. Biol Psychiatry. 1989. 26(2):163–175.

57. Oruc L, Verheyen GR, Furac I, Ivezic S, Jakovljevic M, Van Broockhoven C, et al. Positive association between the GABRA5 gene and unipolar recurrent major depression. Neuropsychobiology. 1997. 36(2):62–64.

58. Zubenko GS, Hughes HB 3rd, Maher BS, Stiffler JS, Zubenko WN, Marazita ML. Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet. 2002. 114(8):980–987.

59. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Poulton R, et al. Influence of life stress on depression : moderation by a polymorphism in the 5-HTT gene. Science. 2003. 301(5631):386–389.